[HTML][HTML] Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice

M Villanueva-Paz, L Morán, N López-Alcántara… - Antioxidants, 2021 - mdpi.com
Idiosyncratic drug-induced liver injury (DILI) is a type of hepatic injury caused by an
uncommon drug adverse reaction that can develop to conditions spanning from …

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis

Z Shubber, A Calmy, I Andrieux-Meyer, M Vitoria… - Aids, 2013 - journals.lww.com
Methods: We systematically reviewed adverse events among treatment-naive HIV-positive
adults and children receiving either NVP or EFV as part of first-line antiretroviral therapy. The …

Antiretroviral drugs and liver injury

V Soriano, M Puoti, P Garcia-Gascó, JK Rockstroh… - Aids, 2008 - journals.lww.com
Antiretroviral drug-related liver injury (ARLI) is a common cause of morbidity, mortality and
treatment discontinuation in HIV-infected patients [1]. Prevention and management of ARLI …

Genetics of Alzheimer's disease

PG Ridge, MTW Ebbert… - BioMed research …, 2013 - Wiley Online Library
Alzheimer's disease is the most common form of dementia and is the only top 10 cause of
death in the United States that lacks disease‐altering treatments. It is a complex disorder …

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

C Wyen, H Hendra, M Vogel, C Hoffmann… - Journal of …, 2008 - academic.oup.com
Objectives The aim of this study was to investigate the frequency of CYP2B6 polymorphisms
(according to ethnicity) and the influence of heterozygosity and homozygosity on plasma …

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition

V Michaud, T Bar-Magen, J Turgeon, D Flockhart… - Pharmacological …, 2012 - ASPET
Significant intra-and interindividual variability has been observed in response to use of
pharmacological agents in treatment of HIV infection. Treatment of HIV infection is limited by …

Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration

DW Haas, JA Bartlett, JW Andersen… - Clinical infectious …, 2006 - academic.oup.com
Associations have been reported between an MDR1 variant and responses to
nonnucleoside reverse-transcriptase inhibitors. We explored associations between MDR1 …

Genetic basis of drug-induced liver injury: present and future

TJ Urban, AK Daly, GP Aithal - Seminars in liver disease, 2014 - thieme-connect.com
There is considerable evidence that susceptibility to idiosyncratic drug-induced liver injury
(DILI) is genetically determined. Though genetic associations with DILI have been reported …

Pharmacogenetics of antiretrovirals

V Tozzi - Antiviral research, 2010 - Elsevier
The introduction of highly active antiretroviral therapy (HAART) as standard of care has
changed the natural history of HIV infection into a manageable chronic disease requiring …

Hypersensitivity reactions to HIV therapy

M Chaponda, M Pirmohamed - British journal of clinical …, 2011 - Wiley Online Library
Many drugs used for the treatment of HIV disease (including the associated opportunistic
infections) can cause drug hypersensitivity reactions, which vary in severity, clinical …